Complete information on: VIKING THERAPEUTICS, INC. branch
Company data, financial data, shareholder information and contact data
| Name: | VIKING THERAPEUTICS, INC. branch |
| Company number: | 4302196 | Company status: | Active |
| Incorporation date: | 28 September 2012 (over 8 years ago) |
| - | |
| Company type: | FOREIGN BUSINESS CORPORATION |
| Jurisdiction: | New York (US) |
| Business number: | unavailable |
| Registered address: | 11119 NORTH TORREY PINES ROAD, SUITE 50, SAN DIEGO, 92037, CALIFORNIA, United States |
| Agent name: | unavailable |
| Previous names: | VIKING THERAPEUTICS, INC. |
| Company addresses: | Head Office Address VIKING THERAPEUTICS, INC., 11119 NORTH TORREY PINES ROAD, SUITE 50, SAN DIEGO, CALIFORNIA, 92037 |
| Latest events: | 2012-09-28 Incorporated2012-09-28 - 2019-12-05 Addition of officer BRIAN LIAN, PH.D, chief executive officer2012-09-28 - 2019-12-05 Addition of officer VIKING THERAPEUTICS, INC., C/O BRIAN LIAN, PH.D, dos process agent |
| Officers: | BRIAN LIAN, PH.D PH.D VIKING THERAPEUTICS, INC., C/O BRIAN LIAN, PH.D INC. |
Officers:
Name:
BRIAN LIAN, PH.D, Position: PH.D
Name:
VIKING THERAPEUTICS, INC., C/O BRIAN LIAN, PH.D, Position: INC.
Data from other sources:
Viking Therapeutics, Inc., US461073877
From: US, CA, San Diego
Contact: www.vikingtherapeutics.com, [email protected], +1 8587044660
Status:
ARROWPOINT ASSET MANAGEMENT LLC via its funds Shareholder of Viking Therapeutics, Inc.
ARROWPOINT ASSET MANAGEMENT LLC via its funds Shareholder of Viking Therapeutics, Inc.
DEUTSCHE BANK AG via its funds Shareholder of Viking Therapeutics, Inc.
DEUTSCHE BANK AG via its funds Shareholder of Viking Therapeutics, Inc.
ARROWMARK COLORADO HOLDINGS LLC Shareholder of Viking Therapeutics, Inc.
ARROWMARK COLORADO HOLDINGS LLC Shareholder of Viking Therapeutics, Inc.
VERITION FUND MANAGEMENT NY, INC. via its funds Shareholder of Viking Therapeutics, Inc.
VERITION FUND MANAGEMENT NY, INC. via its funds Shareholder of Viking Therapeutics, Inc.
STATE OF CALIFORNIA via its funds Shareholder of Viking Therapeutics, Inc.
STATE OF CALIFORNIA via its funds Shareholder of Viking Therapeutics, Inc.
FIERA CAPITAL CORPORATION via its funds Shareholder of Viking Therapeutics, Inc.
FIERA CAPITAL CORPORATION via its funds Shareholder of Viking Therapeutics, Inc.
SCHWEIZERISCHE NATIONALBANK via its funds Shareholder of Viking Therapeutics, Inc.
SCHWEIZERISCHE NATIONALBANK via its funds Shareholder of Viking Therapeutics, Inc.
VANGUARD GROUP INC via its funds Shareholder of Viking Therapeutics, Inc.
VANGUARD GROUP INC via its funds Shareholder of Viking Therapeutics, Inc.
NORTHERN TRUST CORPORATION via its funds Shareholder of Viking Therapeutics, Inc.
NORTHERN TRUST CORPORATION via its funds Shareholder of Viking Therapeutics, Inc.
LSP ADVISORY GROUP B.V. via its funds Shareholder of Viking Therapeutics, Inc.
WELLINGTON MANAGEMENT GROUP LLP via its funds Shareholder of Viking Therapeutics, Inc.
WELLINGTON MANAGEMENT GROUP LLP via its funds Shareholder of Viking Therapeutics, Inc.
INVESCO LTD via its funds Shareholder of Viking Therapeutics, Inc.
SPHERA FUNDS MANAGEMENT LTD Shareholder of Viking Therapeutics, Inc.
BELLEVUE GROUP AG via its funds Shareholder of Viking Therapeutics, Inc.
BELLEVUE GROUP AG via its funds Shareholder of Viking Therapeutics, Inc.
RUBRIC CAPITAL MANAGEMENT LP via its funds Shareholder of Viking Therapeutics, Inc.
RUBRIC CAPITAL MANAGEMENT LP via its funds Shareholder of Viking Therapeutics, Inc.
CHARLES SCHWAB CORPORATION via its funds Shareholder of Viking Therapeutics, Inc.
CHARLES SCHWAB CORPORATION via its funds Shareholder of Viking Therapeutics, Inc.
MACQUARIE GROUP LTD via its funds Shareholder of Viking Therapeutics, Inc.
POINT72 CAPITAL HOLDINGS LP via its funds Shareholder of Viking Therapeutics, Inc.
POINT72 CAPITAL HOLDINGS LP via its funds Shareholder of Viking Therapeutics, Inc.
Mr S. Kathy Rouan Currently works for (Director) Viking Therapeutics, Inc.
Mr Charles A Rowland Currently works for (Independent Director) Viking Therapeutics, Inc.
Mr Michael Morneau Currently works for (Vice President - Finance and Administration) Viking Therapeutics, Inc.
Ms Amy Broidrick Previously worked for (Senior Vice President - Corporate Development) Viking Therapeutics, Inc.
Mr Michael Morneau Previously worked for (Chief Financial Officer) Viking Therapeutics, Inc.
Mr Gregory S Zante Previously worked for (Vice President - Finance and Operations) Viking Therapeutics, Inc.
Mr Lawson Macartney Currently works for (Independent Chairman of the Board) Viking Therapeutics, Inc.
Mr Matthew William Foehr Currently works for (Director) Viking Therapeutics, Inc.
Ms Hiroko Masamune Currently works for (Senior Vice President - Pharmaceutical Development; Chief Development Officer) Viking Therapeutics, Inc.
J. Matthew Singleton Currently works for (Independent Director) Viking Therapeutics, Inc.
Ms Catherine Lee Kelleher Previously worked for (Vice President - Clinical Development) Viking Therapeutics, Inc.
Mr Charles A Rowland Previously worked for (Director) Viking Therapeutics, Inc.
Mr Stephen W Webster Currently works for (Independent Director) Viking Therapeutics, Inc.
Mr Brian W Lian Currently works for (President, Chief Executive Officer, Director) Viking Therapeutics, Inc.
Ms Rochelle Hanley Previously worked for (Chief Medical Officer) Viking Therapeutics, Inc.
Other companies:
All information found on this page is extracted from public sources and should not be used in any official way.